USMLE Step 1 went pass/fail in January 2022. Four years later, the dust has settled, the early panic has faded, and we now have real match data showing how programs actually behave when they cannot rank applicants by a three-digit Step 1 score. If you are an international medical graduate (IMG) preparing for the 2026 match, here is the honest picture of what changed and what you should be doing about it.

What Pass/Fail Actually Did to the IMG Filter

Before 2022, a high Step 1 score was an IMG's most powerful equalizer. A score in the high 240s or 250s could overcome a less prestigious medical school, no US clinical experience, and a limited research record. It was a single number that said, "this applicant can do the work."

That number is gone. What replaced it is not nothing. What replaced it is everything else, weighted more heavily.

Programs still need a way to filter thousands of applications down to a manageable interview list. The filters they use now, in rough order of weight for IMGs:

  • USMLE Step 2 CK score : this is now the de facto numeric filter. Programs use Step 2 CK exactly the way they used to use Step 1.
  • US clinical experience (USCE) : observerships, sub-internships, away rotations. The more US-based the experience, the more weight.
  • Research and publications : especially first-author publications, posters at major conferences, and ongoing projects with US-based mentors.
  • Letters of recommendation from US attendings : these matter more than ever because they are the single most credible signal that the applicant can function in a US clinical environment.
  • ECFMG certification : non-negotiable, but timing matters (more on this below).

The Step 2 CK Score Is Doing the Heavy Lifting

If you are an IMG and you take only one thing away from this article, take this: your Step 2 CK score is now the most important number on your application. It is the one number programs see and use to filter.

The implications are practical. You should:

  • Take Step 2 CK before you submit ERAS, not after. A score-pending applicant is at a real disadvantage.
  • Aim for a competitive score for your target specialty. For internal medicine, that means roughly 250+ to be competitive at university programs. For more competitive specialties, higher.
  • Treat Step 2 CK preparation with the seriousness that students used to reserve for Step 1.

This is a shift from what most IMGs were taught about the timeline. The old advice was Step 1 first, then clinical years, then Step 2 CK in your final year, then submit ERAS. The new advice is: Step 1 (pass), strong clinical years, Step 2 CK earlier than your peers, then submit ERAS with a score in hand.

What This Means for European Medical Students

If you are at Charles University or another European medical school, the timing of your USMLE exams matters more now than it did before pass/fail. Here is the practical framework:

  • Pre-clinical years (1 to 3): Build the foundation. Your basic-science coursework lines up well with Step 1 content. Pass Step 1 confidently, but do not over-invest in it. The score does not exist anymore.
  • Clinical years (4 to 5): Do at least one clinical rotation in the US. This is non-negotiable for a competitive IMG application. Your home rotations matter for grades and letters, but US rotations matter for the application.
  • Sixth year: Take Step 2 CK in the early part of the year, ideally before your home country's final exams pile up. The goal is a strong score in hand by ERAS submission in September.

OET Medicine and ECFMG Timing

One thing pass/fail did not change is the ECFMG certification process. You still need it, and you still need to time it correctly.

The English-proficiency requirement (OET Medicine, IELTS Academic, or TOEFL iBT) is something European medical students sometimes forget about until late. Build it into your timeline. OET Medicine specifically has been gaining traction among IMGs because it is healthcare-contextualized and many find it more aligned with how clinicians actually communicate. Our residency mentorship walks through which English exam to choose based on your background.

The Clinical Skills component formerly known as Step 2 CS is permanently discontinued. ECFMG now uses a pathway-based assessment that varies by candidate situation. Make sure you know which pathway applies to you well before you plan to apply.

Research: From "Nice to Have" to "Strongly Encouraged"

Before pass/fail, IMG applicants without research could sometimes still match into community internal medicine programs on the strength of a high Step 1 score and good interviews. That window has closed for most competitive programs.

The research that matters most:

  • First-author publications, even in mid-tier journals, weigh heavier than coauthorships in big journals.
  • US-based research mentors are more valuable than equally productive home-country mentors, because the letter and the network both travel better.
  • Ongoing projects beat completed projects from years ago. Programs want to see momentum.
  • Specialty-relevant research moves the needle. A nephrology paper for an internal medicine application is fine. A nephrology paper for a dermatology application is wasted.

The Match Numbers

Match data from the past three cycles shows that overall IMG match rates have been remarkably stable, hovering in the high 50s to low 60s for non-US IMGs. The makeup of who matches has shifted somewhat. Applicants with strong Step 2 CK scores, US clinical experience, and research are matching at higher rates. Applicants relying on a single strong metric are matching at lower rates.

The takeaway is not that pass/fail made things harder. It made things more multidimensional. The applicants who succeed in 2026 are the ones who built a complete profile rather than optimizing one number.

What to Do Right Now

If you are an IMG aiming for the 2026 or 2027 match, here is the priority list:

  1. Pass Step 1. Move on. Do not spend extra months chasing perfection on a pass/fail exam.
  2. Pour your test-prep energy into Step 2 CK. Aim for a score that is competitive for your target specialty and program tier.
  3. Plan US clinical experience now. Observerships and away rotations need to be set up months in advance.
  4. Start a research project with a US-based mentor as early as your third year.
  5. Pick your English-proficiency exam early and schedule it well before ERAS season.
  6. Build a list of programs that have a track record of matching IMGs in your target specialty.

The Bottom Line

Pass/fail Step 1 did not make residency applications easier. It made them more honest. The applicants who thrive are the ones who treat the application as a portfolio rather than a single test score. For IMGs, this means leaning into the things that have always mattered most: clinical excellence, research productivity, and demonstrated ability to function in a US healthcare environment.

That is the path we walked, and that is the path we now help our students walk every day.